Meridian Street Capital Research
Investment Thesis
Meridian Street Capital is dedicated to "engineering the future of healthcare alongside early stage trailblazers." The fund partners with exceptional founders at the intersection of healthcare and technology, with a focused investment philosophy that emphasizes deep specialization, early-stage entry, and concentrated portfolio support. The firm believes that the best healthcare companies emerge from disciplined partnerships with visionary founders who combine technical expertise with healthcare domain knowledge.
Sector Focus
Meridian Street Capital invests exclusively at the intersection of healthcare and technology, with a thematically coherent digital health portfolio. The firm focuses on:
- Digital Health Infrastructure: Platforms enabling better healthcare data exchange and interoperability (1upHealth)
- AI/ML Diagnostics: Companies leveraging machine learning for diagnostic improvement and clinical insights (Preemptive AI, Qualtech)
- Virtual Specialty Care: Telehealth and remote specialty care platforms (Included Health, Robin Healthcare)
- Women's Health: Reproductive and women's specific healthcare solutions
- Mental Health & Behavioral Health: Platforms addressing mental wellness and clinical behavioral health (Rula, Treat My OCD, Prava Therapy)
- Care Coordination: Patient engagement and care management tools (Ounce of Care, Band Health)
- Home-Based Care: Infusion therapy, homecare services (Local Infusion, Dina Care)
- Vertically-Integrated Healthcare: Specialized care delivery models
The firm explicitly avoids pure consumer wellness, hardware-only solutions, and companies without meaningful clinical impact.
Stage Focus
Meridian Street Capital focuses on early-stage companies:
- Pre-Seed: $100K-$500K for founding teams and initial product development
- Seed: $500K-$2M for companies with initial customer traction and clinical validation
- Series A: $1M-$5M for companies achieving product-market fit with clear clinical outcomes
The firm prioritizes being a founder's first institutional investor and leads or co-leads the majority of rounds.
Check Size & Deployment
Typical investment range: $100K - $5M
- Pre-seed: $100K-$500K
- Seed: $500K-$2M (most common)
- Series A: $1M-$5M (selective follow-ons)
Fund status: Actively deploying. Recent investments include Quilt Health and Isaac Health (Series A, August 2025), indicating continued active deployment.
Recent Activity & Portfolio
Notable Recent Investments:
- Isaac Health (Series A, August 2025)
- Quilt Health (2025)
- Onboard AI (November 2025) - AI-powered enterprise healthcare systems
- Preemptive AI - Predictive health analytics
- Qualtech - Healthcare AI/quality measurement
- Readout - Health data analytics
Portfolio Highlights (37+ companies):
Exits & Acquisitions:
- Decent (acquired/partnership announced)
- First Dollar (acquisition)
- Hint (acquisition)
- Included Health (successful platform, acquired/grown)
- Tenure (acquisition)
- Valify (acquisition)
Active Portfolio (Notable):
- 1upHealth - Healthcare data interoperability and API platform
- Anatomy - Visual healthcare technology
- Andros - Telehealth for men's health
- Band Health - Healthcare engagement platform
- Closed Loop - AI for healthcare operations
- Dina Care - Home care services
- Isaac Health - Healthcare navigation
- Jona Health - Primary care innovation
- Jukebox Health - Patient engagement through music therapy
- My Isaac Health - Healthcare management
- Ounce of Care - Preventive healthcare
- Prava Therapy - Mental health services
- Preemptive AI - Predictive health analytics
- Qualtech - Healthcare AI and measurement
- Quilt Health - Healthcare cost management
- Readout - Health data analytics
- Rula - Mental health services (therapist marketplace)
- Safe Ride Health - Non-emergency medical transportation
- Treat My OCD - Mental health/behavioral health
- On-Board AI - Enterprise healthcare AI
- Veracity Self Care - Digital therapeutics
- WURU - Healthcare technology
Team
Leadership:
- Scott Law (Partner, General Partner) - Senior investment leader at Meridian Street Capital
- George Ribaroff, MD (Partner) - Physician and healthcare venture investor with clinical background and deep industry expertise
Investment Team:
- Brianna Yarnoff (Investor) - Healthcare investment professional
- Robel Mulugeta (Investor) - Healthcare investment professional
Operations:
- Jimmy Comfort (Venture Partner) - Senior advisor to the firm
The team uniquely blends venture capital expertise with deep clinical and healthcare domain knowledge. This healthcare-first orientation differentiates the firm.
Geographic Focus
Primary focus: United States, with headquarters in New York, New York.
Decision Process & Founder Engagement
- Decision Structure: Partnership (Scott Law and George Ribaroff co-lead decisions)
- Decision Speed: Moderate (typical healthcare VC evaluation rigor for clinical validation)
- Warm Intros: Required (concentrated, relationship-driven fund)
- Involvement: Board seat or observer involvement typical
Investment Philosophy & Differentiation
Meridian Street Capital explicitly uses three key differentiators:
- Specialized - Deep focus exclusively on healthcare technology
- Early - Supporting founders often from day one
- Focused - Concentrated portfolio with steadfast partnership
The firm prioritizes deep relationships and clinical impact over portfolio breadth.
Founder Preferences
The firm backs founders who:
- Have healthcare or clinical domain expertise
- Combine technical/business acumen with authentic healthcare problem identification
- Prioritize clinical outcomes and underserved patient populations
- Include diverse and underrepresented founders
Fund Performance
- Portfolio Size: 37+ invested companies
- Exit Track Record: 6 known exits/acquisitions
- Active Deployment: Recent investments through November 2025
- Founded: 2016 (approximately 9-10 years operating history)